Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Stroke. 2018 Nov;49(11):2590–2596. doi: 10.1161/STROKEAHA.118.021556

Table 3.

Correlation of FCA Severity Score (FCASS) with acute serum levels of inflammatory markers measured in the VIPS study*

Baseline FCASS Maximum FCASS
n=36
n=36**
Serum Inflammatory Marker Spearman’s rho p-value Spearman’s rho p-value

hsCRP 0.35 0.036 0.47 0.004
MPO 0.30 0.08 0.28 0.10
SAA 0.20 0.24 0.27 0.11
TNF-α −0.05 0.75 −0.16 0.34

hsCRP=human C-reactive protein; SAA=serum amyloid A; MPO=myeloperoxidase; TNF-α=tumor necrosis factor alpha

*

Inflammatory markers were not available for 5 of the 41 FCA patients.

**

For those with no follow-up imaging, the baseline score was considered to be the maximum score.